The use of epitope arrays in immunodiagnosis of infectious disease: hepatitis C virus, a case study.
暂无分享,去创建一个
Jonathan M Gershoni | J. Gershoni | Dror D. Siman-Tov | Dror D Siman-Tov | Romy Zemel | Ran Tur Kaspa | R. Zemel | R. Tur Kaspa
[1] M. Mondelli,et al. Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody , 1994, Journal of virology.
[2] D. MacPhee. Methodological considerations for improving Western blot analysis. , 2010, Journal of pharmacological and toxicological methods.
[3] P. Hornbeck,et al. Enzyme‐Linked Immunosorbent Assays , 1992, Current protocols in immunology.
[4] K. Chayama,et al. Factors predictive of response to interferon‐α therapy in hepatitis C virus infection , 1994, Hepatology.
[5] K. Vattem,et al. Performing and optimizing Western blots with an emphasis on chemiluminescent detection. , 2009, Methods in enzymology.
[6] V. Petrenko,et al. Design of specific immunogens using filamentous phage as the carrier. , 1993, Gene.
[7] G. Morris,et al. Hepatitis C epitopes from phage‐displayed cDNA libraries and improved diagnosis with a chimeric antigen , 2000, Journal of medical virology.
[8] Franco Felici,et al. Identification of tumor‐associated antigens by screening phage‐displayed human cDNA libraries with sera from tumor patients , 2003, International journal of cancer.
[9] K. Reddy,et al. Hepatitis C Virus Genotypes in the United States: Epidemiology, Pathogenicity, and Response to Interferon Therapy , 1996, Annals of Internal Medicine.
[10] E. Kolho. Specificity and sensitivity of first and second generation anti‐HCV ELISA in a low prevalence population , 1992, Transfusion medicine.
[11] S. Richter. Laboratory Assays for Diagnosis and Management of Hepatitis C Virus Infection , 2002, Journal of Clinical Microbiology.
[12] J. Gershoni,et al. Phage Display Selection, Analysis, and Prediction of B Cell Epitopes , 2009, Current protocols in immunology.
[13] A. Meola,et al. Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. , 1996, Journal of immunology.
[14] N. Haigwood,et al. Differentiation of a passive vaccine and the humoral immune response toward infection: analysis of phage displayed peptides. , 2006, Vaccine.
[15] Jules L. Dienstag,et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis , 1989 .
[16] Y. Wang,et al. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C , 1994, Journal of medical virology.
[17] M. Pirisi,et al. Identification of four epitopes in hepatitis C virus core protein , 1993, Journal of clinical microbiology.
[18] Y. Shemer-Avni,et al. Hepatitis C virus infection and genotypes in Southern Israel and the Gaza strip , 1998, Journal of medical virology.
[19] Stephen L. Chen,et al. The Natural History of Hepatitis C Virus (HCV) Infection , 2006, International journal of medical sciences.
[20] Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase , 2004, Journal of medical virology.
[21] J. Gershoni,et al. The rational design of a 'type 88' genetically stable peptide display vector in the filamentous bacteriophage fd. , 2001, Nucleic acids research.
[22] G. Paranhos-Baccala,et al. HCV core immunodominant region analysis using mouse monoclonal antibodies and human sera: Characterization of major epitopes useful for antigen detection , 1998, Journal of medical virology.
[23] B. Kurien,et al. An overview of Western blotting for determining antibody specificities for immunohistochemistry. , 2011, Methods in molecular biology.
[24] G. Opdenakker,et al. Localization and reactivity of an immunodominant domain in the NS3 region of hepatitis C virus , 1995, Journal of medical virology.
[25] J. Schapiro,et al. Hepatitis C at the Israeli National Hemophilia Center , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.
[26] B. Wahrén,et al. Immune response to a single peptide containing an immunodominant region of hepatitis C virus core protein: the isotypes and the recognition site. , 1992, Immunology letters.
[27] G. E. Morris,et al. Identification of antigenic sites on three hepatitis C virus proteins using phage‐displayed peptide libraries , 1998, Journal of medical virology.
[28] H J Alter,et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. , 1990, Science.
[29] J. Glenn,et al. The Evolution of the Major Hepatitis C Genotypes Correlates with Clinical Response to Interferon Therapy , 2009, PloS one.
[30] E. Stura,et al. Crystal Structure of a Hydrophobic Immunodominant Antigenic Site on Hepatitis C Virus Core Protein Complexed to Monoclonal Antibody 19D9D6 1 , 2003, The Journal of Immunology.
[31] F. Fabrizi,et al. Automated RIBA Hepatitis C Virus (HCV) Strip Immunoblot Assay for Reproducible HCV Diagnosis , 1998, Journal of Clinical Microbiology.
[32] K. Matsumoto,et al. Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens , 1993, Journal of clinical microbiology.
[33] G. Davis,et al. Factors predictive of a beneficial response to therapy of hepatitis C , 1997, Hepatology.
[34] J. Gershoni,et al. Site directed biotinylation of filamentous phage structural proteins , 2011, Virology Journal.
[35] Darius Moradpour,et al. Replication of hepatitis C virus , 2007, Nature Reviews Microbiology.
[36] W. Maskill,et al. 4 Application of Protein Blotting to the Serodiagnosis of Human Immunodeficiency Virus Infection , 1989 .
[37] S. Lambert,et al. Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides. , 1995, Virology.
[38] M. Houghton. The long and winding road leading to the identification of the hepatitis C virus. , 2009, Journal of hepatology.
[39] A. Palacios,et al. Development of low cost peptide‐based anti‐hepatitis C virus screening and confirmatory assays: Comparison with commercially available tests , 1999, Journal of medical virology.
[40] B. Wahrén,et al. Immunodominant regions within the hepatitis C virus core and putative matrix proteins , 1992, Journal of clinical microbiology.
[41] L. Peruski,et al. Immunological Methods for Detection and Identification of Infectious Disease and Biological Warfare Agents , 2003, Clinical Diagnostic Laboratory Immunology.
[42] Darius Moradpour,et al. Structural biology of hepatitis C virus , 2004, Hepatology.
[43] H. Grisé,et al. Cellular and molecular biology of HCV infection and hepatitis. , 2009, Clinical science.
[44] T. Berg,et al. Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes. , 1996, Journal of hepatology.
[45] F. Felici,et al. ADAM-HCV, a new-concept diagnostic assay for antibodies to hepatitis C virus in serum. , 2001, European journal of biochemistry.
[46] P. Simmonds,et al. Sequence variability of hepatitis C virus and its clinical relevance , 1994, Journal of viral hepatitis.